{"organizations": [], "uuid": "eade549fb78b9635c9e9b156a530a219b694776f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/fda-iqvia-holdings/fda-finds-inaccuracy-in-iqvia-sales-data-on-some-opioids-idUSL3N1SN5ES", "country": "US", "domain_rank": 408, "title": "FDA finds inaccuracy in IQVIA sales data on some opioids", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-16T19:50:00.000+03:00", "replies_count": 0, "uuid": "eade549fb78b9635c9e9b156a530a219b694776f"}, "author": "", "url": "https://www.reuters.com/article/fda-iqvia-holdings/fda-finds-inaccuracy-in-iqvia-sales-data-on-some-opioids-idUSL3N1SN5ES", "ord_in_thread": 0, "title": "FDA finds inaccuracy in IQVIA sales data on some opioids", "locations": [], "entities": {"persons": [{"name": "arun koyyur", "sentiment": "none"}, {"name": "mrinalini krothapalli", "sentiment": "none"}, {"name": "anuron kumar mitra", "sentiment": "none"}], "locations": [{"name": "united states", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "iqvia holdings inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "iqvia", "sentiment": "none"}, {"name": "u.s. food & drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 16, 2018 / 4:51 PM / Updated 10 minutes ago FDA finds inaccuracy in IQVIA sales data on some opioids Reuters Staff 1 Min Read\nMay 16 (Reuters) - The U.S. Food & Drug Administration said on Wednesday it discovered inaccuracies in sales data provided by IQVIA Holdings Inc, a vendor it contracts, regarding some opioid drug products.\nThe regulator said here the data showed a more than 20 percent drop in the reported kilogram amount of prescription opioid fentanyl sold in the United States for at least the past five years, compared with what was previously reported.\nIQVIA collects data to measure the volume of drugs sold by manufacturers and wholesalers to pharmacies and hospitals. (Reporting by Mrinalini Krothapalli and Anuron Kumar Mitra; Editing by Arun Koyyur)", "external_links": ["https://www.fda.gov/Drugs/DrugSafety/ucm607823.htm"], "published": "2018-05-16T19:50:00.000+03:00", "crawled": "2018-05-16T20:09:51.004+03:00", "highlightTitle": ""}